Dechert advises DDC in Acquisition of Orchid Cellmark’s Government Paternity Business
December 19, 2011
Dechert News Release
DDC (DNA Diagnostics Center), one of the largest DNA testing companies in the world, announced today the acquisition of Orchid Cellmark, Inc.’s (Orchid Cellmark) government paternity business. Orchid Cellmark, a leading international provider of DNA testing services primarily for forensic and family relationship applications, is now a wholly-owned subsidiary of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH).
Dechert partner James A. Fishkin and associate Rani A. Habash are providing antitrust counsel to DDC, while partner Stephen M. Leitzell and associate James Cosgrove are advising on corporate matters.
In addition, the FTC has issued a press release on this matter.